DNA shuffling: Induced molecular breeding to produce new generation long-lasting vaccines

Biotechnology Advances

Volumn 20, Issue 3-4, 2002, Pages 229-238

  Marshall, Sergio H ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

Author keywords

Chimeric gene products; DNA shuffling; Induced evolution; Optimized gene expression; Tangling pathogen survival

Indexed keywords

ANTIBODIES; DISEASES; DNA; GENES; IMMUNOLOGY; VACCINES;

INDUCED MOLECULAR BREEDING;

BIOTECHNOLOGY;

VACCINATION;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; VERTEBRATA;

EID: 0036845827     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0734-9750(02)00015-0     Document Type: Article

References (47)

1. Achtman M., Zurth K., Morelli G., Torrea G., Guiyoule A., Carniel E. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc. Natl. Acad. Sci. U.S.A. 96:1999;14043-14048.
2. Alm R.A., Ling L.S., Moir D.T., King B.L., Brown E.D., Doig P.C., Smith D.R., Noonan B., Guild B.C., de Jonge B.L., Carmel G., Tumimimo P.J., Caruso A., Urianickelsen M., Mills D.M., Ives C., Gibson R., Merberg D., Mills S.D., Jiang Q., Taylor D.E., Vovis G.F., Trust T.J. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature. 397:1999;176-180.
3. Berzofsky J.A., Ahlers J.D., Belyakov I.M. Strategies for designing and optimizing new generation vaccines. Nat. Rev. Immunol. 1:2001;209-219.
4. Borscheuer U.T., Pohl M. Improved biocatalysts by directed evolution and rational protein design. Curr. Opin. Chem. Biol. 5:2001;137-143.
5. Burbank L. Short-cuts into the centuries to come: better plants secured by hurrying evolution. Whitson J., Williams R.J.H.S. Luther Burbank: his methods and discoveries: their practical applications. vol. 1:1914;176-210 Luther Burbank, New York.
6. Crameri A.C., Raillard S., Stemmer W.P.C. DNA shuffling of a family of genes from diverse species accelerates directed evolution. Nature. 391:1998;288-291.
7. Fairbrother W.J., Gordon N.C., Humke E.W., O'Rourke K.M., Starovasnik M.A., Yin J.-P., Dixit V.M. The PYRIN domain: a member of the death domain-fold superfamily. Protein Sci. 10:2001;1911-1918.
8. Ginsberg HS, Robinson HL, Davies HL, Johnston SA, Liu MA. The scientific future of DNA for immunization. A report. The American Academy of Microbiology, http://www.asmusa.org/acasrc/aca1.htm, 1997.
9. Gupta S., Maiden M.C.J. Exploring the evolution of diversity in pathogens populations. Trends Microbiol. 9:2001;181-185.
10. Gurunathan S., Klinman D.M., Seder R.A. DNA vaccines: immunology, application and optimization. Annu. Rev. Immunol. 18:2000;927-974.
11. Hassanin A., Golub R., Lewis S.M., Wu G.E. Evolution of the recombination signal sequences in the Ig heavy-chain variable region locus of mammals. Proc. Natl. Acad. Sci. U.S.A. 97:2000;11415-11420.
12. Horwich A.L., Weissman J.S. Deadly conformations protein misfolding in prion disease. Cell. 89:1997;499-510.
13. Hughes A.L. Origin and evolution of viral interleukin-10 and other DNA virus genes with vertebrate homologues. J. Mol. Evol. 54:2002;90-101.
14. Lecuit M., Vandormael-Pournin S., Lefort J., Huerre M., Gounon P., Dupuy C., Babinet C., Cossart P. A transgenic model for Listeriosis: role of internalin in crossing the intestinal barrier. Science. 292:2001;1722-1725.
15. Litman G.W., Anderson M.K., Rast J.P. Evolution of antigen binding receptors. Annu. Rev. Immunol. 17:1999;109-147.
16. Lobry J.R. Asymmetric substitution patterns in the two DNA strands of bacteria. Mol. Biol. Evol. 13:1996;660-665.
17. Makino S.I., Watarai M., Tabuchi H., Shirahata T., Furuoka H., Kobayashi Y., Takeda Y. Genetically modified Shiga toxin 2 e(stx2e) producing Escherichia coli is a vaccine candidate for porcine edema disease. Microb. Pathog. 31:2001;1-8.
18. Matsumara I., Ellington A.D. In vitro evolution of thermostable p53 variants. Protein Sci. 8:1999;731-740.
19. Mayr E. The growth of biological thought: diversity, evolution and inheritance. 1982;Belknap Press of Harvard University Press, Cambridge (MA).
20. McKenzie G.J., Lee P.L., Lombardo M.J., Hastings P.J., Rosemberg S.M. SOS mutator DNA polymerase IV functions in adaptive mutation and not adaptive amplification. Mol. Cell. 7:2001;571-579.
21. Moore G.L., Maranas C.D., Lutz S., Benkovic S.J. Predicting crossover generation in DNA shuffling. Proc. Natl. Acad. Sci. U.S.A. 98:2001;3226-3231.
22. Olivera B.M. Conus venom peptides, receptors and ion channels targets and drug design: 50 million years of neuropharmacology. Mol. Biol. Cell. 8:1997;2101-2109.
23. Overbaugh J., Bangham C.R.M. Selection forces and constrains on retroviral sequence variation. Science. 292:2001;1106-1109.
24. Parkhill J., Wren B.W., Thomson N.R., Tiball R.W., Holden M.T.G., Prentice M.B., Sebahlia M., James K.D., Churcher C., Mungall K.L., Baker S., Basham D., Bentley S.D., Brooks K., Cerdeño-Tárraga A.M., Chillingworth T., Cronin A., Davies R.M., Davis P., Dougan G., Feltwell T., Hamlin N., Holroyd S., Jagels K., Karlyshev A.V., Leather S., Moule S., Oyston P.C.F., Quail M., Rutherford K., Simmonds M., Skelton J., Stevens K., Whitehead S., Barrell B.G. Genome sequence of Yersinia pestis, the causative agent of plague. Nature. 413:2001;523-527.
25. Patten P.A., Howard R.J., Stemmer W.P.C. Applications of DNA shuffling to pharmaceuticals and vaccines. Curr. Opin. Biotechnol. 8:1997;724-733.
26. Petra P.H., Adman E.T., Orr W.R., Woodcock K.T., Groff C., Sui L.M. Arginine-140 and isoleucine-141 determine the 17β-estradiol-binding specificity of the sex-steroid-binding protein (SBP or SHBG) of human plasma. Protein Sci. 10:2001;1811-1821.
27. Pol E., Björk Role of the single cysteine residue, Cys3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases. Protein Sci. 10:2001;1729-1738.
28. Ponting C.P., Mott R., Bork R., Copley R.C. Novel protein domains and repeats in Drosophila melanogaster: insights into structure, function, and evolution. Genome Res. 11:2001;1996-2008.
29. Prescott D.M. The unusual organization and processing of genomic DNA in hypotrichous ciliates. Trends Genet. 8:1992;439-445.
30. Rosemberg S.M. Evolving responsively: adaptive mutation. Nat. Rev. Genet. 2:2001;504-515.
31. Shapiro J.A. A 21st century view of evolution. J. Biol. Phys. 2002;. In press, Proceedings of the 4th International Conference on Biological Physics, Kyoto, Japan, July 30-August 3.
32. 2-microglobulin in amyloidosis in vitro. Protein Sci. 10:2001;1775-1784.
33. Snidjer H.J., Van Eerde J.H., Gingma R.L., Kalk H.H., Dekker N., Egmond M.R., Dijkstra B.W. Structural investigations of the active-site mutant Asn 156Ala of outer membrane phospholipase A: function of the Asn-His interaction in the catalytic triad. Protein Sci. 10:2001;1962-1969.
34. Staudt L.M., Brown P.O. Genomic views of the immune system. Annu. Rev. Immunol. 18:2000;829-859.
35. Stemmer W.P.C. Rapid evolution of a protein by DNA shuffling. Nature. 370:1994;389-391.
36. Stemmer W.P.C. DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. Proc. Natl. Acad. Sci. U.S.A. 91:1994;10747-10751.
37. Suerbaum S. Genetic variability within Helicobacter pylori. Int. J. Med. Microbiol. 290:2000;175-181.
38. Suerbaum S., Maynard Smith J., Bapurnia K., Morelli G., Smith N.H., Kuntsman D., Dyrek I., Achtman M. Free recombination within Helicobacter pylori. Proc. Natl. Acad. Sci. U.S.A. 95:1998;12619-12624.
39. Tian M., Alt F.W. RNA editing meets DNA shuffling. Nature. 407:2000;31-32.
40. Tomb J.F., Whitte O., Kerlavage A.R., Clayton R.A., Sutton G.G., Fleischman R.D., Ketchum K.A., Klenk H.P., Gill S., Dougherty B.A., Nelson K., Quackenbush J., Zhou L., Kirkness E.F., Peterson S., Loftus B., Richardson D., Dodson R., Khalak H.G., Glodek A., McKenney K., Fitzgerald L.M., Lee N., Adams M.D., Hickey E.K., Berg D.E., Gocayne J.D., Utterback T.R., Peterson J.D., Kelley J.M., Cotton M.D., Weidman J.M., Fujii C., Bowman C., Watthey L., Wallin E., Hayes W.S., Borodovsky M., Karp P.D., Smith H.O., Fraser C.M., Venter J.C. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 387:1997;538-545.
41. Tonegawa S. Somatic generation of antibody diversity. Nature. 302:1983;575-587.
42. Whalen R.G., Kaiwar R., Soong N.W., Punnonen J. DNA shuffling and vaccines. Curr. Opin. Mol. Ther. 3:2001;31-36.
43. Wiesendanger M., Scharff M.D., Edlemann W. Somatic hypermutation, transcription, and DNA mismatch repair. Cell. 94:1998;415-418.
44. Wright B.E. A biochemical mechanism for nonrandom mutations and evolution. J. Bacteriol. 182(11):2000;2993-3001.
45. Zhang J., Alt F.W., Honjo T. Regulation of class switch recombination of the immunoglobulin heavy chain genes. Honjo T., Alt T.W., Rabbitts T.H. Immunoglobulin genes. 2nd edn. 1995;235-265 Academic Press Ltd. New York.
46. Zhang Y., Wu X., Yuang F., Xie Z., Wang Z. Highly frequent frameshift DNA synthesis by human DNA polymerase μ Mol. Cell Biol. 21:2001;7995-8006.
47. Zhao H., Arnold F.H. Optimization of DNA shuffling for high fidelity recombination. Nucleic Acids Res. 25:1997;1307-1308.